| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,572 |
40,899 |
$6.67M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,500 |
5,463 |
$788K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,273 |
5,258 |
$786K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,504 |
4,334 |
$649K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,612 |
3,582 |
$537K |
| 87428 |
|
7,782 |
7,492 |
$464K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,750 |
3,131 |
$463K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,170 |
2,073 |
$304K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,103 |
12,965 |
$220K |
| G9153 |
Mapcp demonstration - physician incentive pool |
3,716 |
3,618 |
$110K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,288 |
10,845 |
$47K |
| 99442 |
|
1,470 |
1,350 |
$47K |
| 99441 |
|
1,983 |
1,768 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
842 |
822 |
$33K |
| 90834 |
Psychotherapy, 45 minutes with patient |
193 |
179 |
$25K |
| 99188 |
|
2,719 |
2,709 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,546 |
1,841 |
$14K |
| 90461 |
|
4,981 |
4,921 |
$14K |
| 81003 |
|
8,961 |
8,650 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
48 |
48 |
$6K |
| 90832 |
Psychotherapy, 30 minutes with patient |
50 |
43 |
$5K |
| 99383 |
|
38 |
38 |
$5K |
| 87420 |
|
1,545 |
1,484 |
$5K |
| 0071A |
|
84 |
84 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
29 |
29 |
$3K |
| 0072A |
|
67 |
67 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,367 |
1,308 |
$3K |
| 92551 |
|
838 |
837 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
17 |
17 |
$2K |
| 96160 |
|
77 |
77 |
$822.11 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
38 |
36 |
$630.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
152 |
151 |
$570.84 |
| 90651 |
|
612 |
604 |
$448.32 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
124 |
113 |
$251.79 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
68 |
68 |
$168.54 |
| 90620 |
|
78 |
77 |
$167.90 |
| 81025 |
|
111 |
108 |
$151.54 |
| 90686 |
|
4,254 |
4,230 |
$77.44 |
| 90723 |
|
715 |
711 |
$77.27 |
| 90633 |
|
771 |
768 |
$64.48 |
| 96127 |
|
732 |
731 |
$53.23 |
| 90700 |
|
27 |
25 |
$52.16 |
| 90647 |
|
772 |
769 |
$51.38 |
| 83655 |
|
13 |
13 |
$41.95 |
| 85018 |
|
13 |
13 |
$9.84 |
| 85014 |
|
12 |
12 |
$8.20 |
| 90670 |
|
2,032 |
2,025 |
$0.00 |
| 90715 |
|
173 |
169 |
$0.00 |
| 90734 |
|
257 |
251 |
$0.00 |
| 99173 |
|
466 |
465 |
$0.00 |
| 90681 |
|
43 |
43 |
$0.00 |
| 90710 |
|
16 |
16 |
$0.00 |
| 90698 |
|
75 |
75 |
$0.00 |
| 90677 |
|
209 |
207 |
$0.00 |
| 90696 |
|
31 |
31 |
$0.00 |
| 90619 |
|
32 |
28 |
$0.00 |
| 90744 |
|
44 |
44 |
$0.00 |
| 90656 |
|
194 |
194 |
$0.00 |
| 91307 |
|
89 |
87 |
$0.00 |
| 96161 |
|
12 |
12 |
$0.00 |